New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows immunocompromised patients using rituximab (a drug used to treat diseases like rheumatoid arthritis) were able ...
Nov 2, 2021
0
9
The OCTAVE study—a multi-center, UK-wide trial, led by the University of Glasgow and co-ordinated by the University of Birmingham's Cancer Research UK Clinical Trials Unit—is evaluating the immune responses following ...
Aug 25, 2021
0
4
Patients receiving in-hospital dialysis treatment for kidney disease produce a larger neutralizing antibody response when given the Pfizer-BioNTech COVID-19 vaccine, compared to the Oxford-AstraZeneca vaccine, according to ...
Aug 13, 2021
0
322
Researchers from Skoltech and their colleagues have studied the longest confirmed case of COVID-19 in an immunocompromised patient who was infected for 318 days. The study revealed new ways in which the virus can mutate to ...
Aug 2, 2021
0
42
Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration ...
Apr 28, 2021
0
5
More than 74 million Americans have thus far been fully vaccinated against COVID-19 – that's a fraction of the U.S. population. Vaccines are perhaps the best hope, along with following safety protocols, for ending the pandemic. ...
Apr 14, 2021
0
3
People with cancers of the blood, bone marrow or lymph nodes are at an increased risk of not making protective coronavirus antibodies after COVID-19 vaccination, a new study warns.
Apr 12, 2021
0
4
People with HIV who were hospitalized with COVID-19 didn't have worse results than COVID-19 patients without HIV, new research shows.
Jul 3, 2020
0
67
Cryptococcus neoformans is a fungal pathogen usually affecting immunocompromised patients, particularly AIDS and organ transplant patients, and is one that can be lethal. Current treatments against cryptococcosis are often ...
Feb 7, 2018
0
1
In HIV-infected patients receiving antiretroviral therapy (ART), chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is associated with an increased risk for non-Hodgkin's lymphoma. The findings are published ...
Oct 17, 2016
0
0
